2025 · Advanced Science

Novel Bivalent mRNA‐LNP Vaccine for Highly Effective Protection against Pneumonic Plague

Elia, Uri; Levy, Yinon; Cohen, Hila; Zauberman, Ayelet, and 9 others

Verdict

UNSCIENTIFIC

The study only partly follows the scientific method inside its paradigm, and the paradigm itself does not pass. The worse layer decides. The verdict is unscientific.

1·Study methodology · inside the paradigm

MIXED

Partly follows the scientific method within Germ Theory.

2·Paradigm · Germ Theory

UNSCIENTIFIC

Fails the tests. The worse layer decides.

How the verdict is decided

The verdict grades both layers: the paradigm this study assumes, and how the study was carried out inside it. Both must be scientific for the whole thing to be scientific. A clean method inside an unscientific paradigm is unscientific. An unscientific method inside a better paradigm is unscientific. A split on either layer is mixed. The worse layer decides.

1·Study methodology

Did this study test its claim with methods that are independent, falsifiable, and non-circular?

MIXED

This study claims that a two-part mRNA injection protects mice from pneumonic plague after a nose dose of cultured bacteria set at 10 to 100 times the killing dose. The tests split.

Independently Verifiable

Pass

The claim that carries the survival tables is whether each mouse was alive or dead after the nose dose, and anyone can count that.

Falsifiable

Fail

The unvaccinated mice had to die: the nose dose was already set at 10 or 100 times the killing amount, so leftover survivors could be written up as protection against plague.

Non-Circular

Fail

High titers sat next to dead mice, so titers were dropped; a cell-killing test built as the stand-in for protection missed mice that lived, so cell-mediated immunity was added to cover the gap.

Why

They grew the culture, counted the colonies, and put ten or a hundred times the already-measured killing dose up the nose of anesthetized mice. The unvaccinated animals were dead by day four because that is what the dose was for. Then whichever injection left mice standing was called protection against pneumonic plague. Binding titers were high in a group that almost all died, so titers were demoted. A cell-killing test they had already built as the stand-in for protection also missed mice that lived, so they added cell-mediated immunity. They did not fake who lived. They built the contrast first and wrote the story backward from it.

2·Paradigm · Germ Theory

Does the framework this study assumes pass the three tests?

UNSCIENTIFIC

Independently Verifiable

Fail

Nobody saw a germ kill a mouse, only a culture already named the plague germ going up the nose and mice dying afterward.

Falsifiable

Fail

If every injected mouse had died, germ theory would have blamed the antigen, the dose, or the expression, not the claim that a cultured germ causes plague.

Non-Circular

Fail

The arms are built as antigen-coded injection versus none, the challenge is a culture already named the plague germ, and the titers are read as that same germ being blocked.

Why

They started from two things already decided: a culture they already named the cause of plague, and the rule that the unvaccinated arm has to lose. Then they set the nose dose at ten or a hundred times the killing amount so that rule would hold. Leftover survivors were written as a vaccine working. The titers, the cell-killing test, and cell-mediated immunity were walked backward from who lived so the result would look like it had been found. That is not two datasets compared without a theory. The comparison was built from germ theory before a mouse was counted. If every injected mouse had died, the field would have changed the antigen or the dose, not the claim that a germ causes plague.

From the study

Results
In contrast, vaccination with SP‐lcrV afforded very little protection, with only 12.5% (1 animal) survival, despite the high anti‐LcrV IgG titers measured prior to the challenge
Results
The survival of animals displaying low neutralizing capacity (<20%) of anti‐LcrV antibodies suggest that the mRNA‐LNP vaccine platform may have activated additional protective mechanisms such as cell‐mediated immunity.
Results
We have previously developed a highly sensitive in vitro macrophage cytotoxicity neutralization assay that enables the calculation of the neutralizing capacity of anti‐LcrV serum antibodies as an in vitro correlate of plague protective immunity in mice.
Results
In contrast, no luminescent signal was detected in vaccinated mice (receiving 3 doses of SP‐lcrV‐hFc and SP‐caf1‐hFc mRNA), indicating that the vaccination elicited robust immune responses that successfully cleared the bacteria.